Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia

Art Schuermans1,2,3, Buu Truong1,2, Maddalena Ardissino4,5

  • 1Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

JAMA Cardiology
|January 3, 2024
PubMed

Insights

This study identified specific cardiovascular disease-related proteins associated with hypertensive disorders of pregnancy (HDPs). Findings suggest potential therapeutic targets for reducing HDP risk and long-term cardiovascular disease in affected women.

Area of Science:

  • Cardiovascular Disease Research
  • Reproductive Health
  • Genetics and Genomics

Background:

  • Hypertensive disorders of pregnancy (HDPs) significantly contribute to maternal morbidity and mortality globally.
  • Women with HDPs have an increased risk of long-term cardiovascular disease.

Purpose of the Study:

  • To identify circulating proteins associated with hypertensive disorders of pregnancy (HDPs).
  • To explore potential therapeutic targets for HDPs and associated cardiovascular risks.

Main Methods:

  • Two-sample Mendelian randomization (MR) was used to test associations between genetic instruments for cardiovascular disease-related proteins and HDPs.
  • Downstream analyses included a systematic review of observational data and phenome-wide MR analyses.

Main Results:

  • Genetic associations were found for 4 proteins with gestational hypertension and 2 proteins with preeclampsia.
  • Observational data supported findings for NT-proBNP, HSP27, and ECP in relation to HDP risk.
  • Phenome-wide MR identified 37 unique non-HDP-related protein-disease associations.

Conclusions:

  • The study suggests genetic links between specific cardiovascular proteins and HDPs.
  • Further research is needed to evaluate the efficacy of targeting these protein pathways to mitigate HDP risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
94
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
31
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K